(Q104389152)

3'-(prop-2-en-1-yl)-[1,1'-biphenyl]-2,4',5-triol

1 reference

1 reference

1 reference

(E)-3-[3-[5-[(2R)-2,3-dihydroxypropyl]-2-hydroxyphenyl]-4-hydroxyphenyl]prop-2-enal

1 reference

1 reference

5'-(prop-2-en-1-yl)-[1,1'-biphenyl]-2,2',5-triol

1 reference

1 reference

1 reference

1 reference

2-Methoxy-4-[(1R,2S)-1,3-dihydroxy-2-[2-methoxy-4-(3-hydroxypropyl)phenoxy]propyl]phenol

1 reference

1 reference

(2R,3S)-3-[4-hydroxy-3-(4-hydroxy-3-prop-2-enylphenyl)phenyl]-3-methoxypropane-1,2-diol

1 reference

1 reference

2-[2-hydroxy-3-[(1S,6S)-3-methyl-6-propan-2-ylcyclohex-2-en-1-yl]-5-prop-2-enylphenyl]-6-[(1S,6S)-3-methyl-6-propan-2-ylcyclohex-2-en-1-yl]-4-prop-2-enylphenol

1 reference

(2R)-3-[4-hydroxy-3-(4-hydroxy-3-prop-2-enylphenyl)phenyl]propane-1,2-diol

1 reference

Episyringaresinol 4'-O-beta-D-glncopyranoside

1 reference

(2S,3R)-2-[4-hydroxy-3-(2-hydroxy-5-prop-2-enylphenyl)phenyl]-3-(hydroxymethyl)-7-(2-hydroxy-5-prop-2-enylphenyl)-2,3-dihydro-1-benzofuran-5-ol

1 reference

3-[4-Hydroxy-3-(4-hydroxy-3-prop-2-enylphenyl)phenyl]prop-2-enal

1 reference

(E)-3-[4-hydroxy-3-(2-hydroxy-5-prop-2-enylphenyl)phenyl]prop-2-enal

1 reference

4-[(2R,3R)-3-[3,4-dihydroxy-5-(4-prop-2-enylphenoxy)phenyl]-2,3-dihydroxypropyl]-5-prop-2-enyl-3-(4-prop-2-enylphenoxy)benzene-1,2-diol

1 reference

4-prop-2-enyl-2-[5-prop-2-enyl-2-[[(1S,2R,4S)-1,7,7-trimethyl-2-bicyclo[2.2.1]heptanyl]oxy]phenyl]phenol

1 reference

(1R,2R)-1-[4-hydroxy-3-(2-hydroxy-5-prop-2-enylphenyl)phenyl]-3-[2-(2-hydroxy-5-prop-2-enylphenyl)-4-prop-2-enylphenoxy]propane-1,2-diol

1 reference

1 reference

1 reference

1 reference

1 reference

4-Hydroxy-2-(4-hydroxy-3-prop-2-enylphenyl)benzaldehyde

1 reference

1 reference

4-[3-[3,4-Dihydroxy-5-(3-prop-2-enylphenoxy)phenyl]-2,3-dihydroxypropyl]-5-prop-2-enyl-3-(4-prop-2-enylphenoxy)benzene-1,2-diol

1 reference

1 reference

1 reference

1 reference

1 reference

People's Republic of China

0 references

GURROCUXXQHGSP-UHFFFAOYSA-N

1 reference

1 reference

Shoji YAHARA

1

1 reference

http://api.crossref.org/works/10.1248%2Fcpb.39.2024

Takashi NISHIYORI

2

1 reference

http://api.crossref.org/works/10.1248%2Fcpb.39.2024

Akihide KOHDA

3

1 reference

http://api.crossref.org/works/10.1248%2Fcpb.39.2024

Toshihiro NOHARA

4

1 reference

http://api.crossref.org/works/10.1248%2Fcpb.39.2024

Itsuo NISHIOKA

5

1 reference

http://api.crossref.org/works/10.1248%2Fcpb.39.2024

publication date

1991

1 reference

stated in

Crossref

retrieved

16 September 2022

full work available at URL

https://www.jstage.jst.go.jp/article/cpb1958/39/8/39_8_2024/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1248/cpb.39.2024?email=unpaywall_01@example.com

published in

Chemical & Pharmaceutical Bulletin

1 reference

http://api.crossref.org/works/10.1248%2Fcpb.39.2024

volume

39

1 reference

http://api.crossref.org/works/10.1248%2Fcpb.39.2024

issue

8

1 reference

http://api.crossref.org/works/10.1248%2Fcpb.39.2024

page(s)

2024-2036

1 reference